Pharmacoeconomic analysis of the use of a fixed combination of tiotropium bromide and olodaterol as maintenance therapy in patients with chronic obstructive pulmonary disease in the Russian Federation
Objective: to evaluate the pharmacoeconomic effectiveness of the use of a fixed double combination of tiotropium bromide + olodаterol in order to treat chronic obstructive pulmonary disease (COPD) in comparison with less expensive monotherapy with long-acting beta-2-agonists (LABA) or long-acting an...
Saved in:
Main Authors: | S. К. Zyryanov, I. N. Dyakov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2022-07-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/688 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD
by: E. G. Kosolapov, et al.
Published: (2017-08-01) -
Pharmacoeconomic analysis of tiotropium bromide and olodaterol fixed combination as maintenance therapy for patients with COPD in the Russian Federation
by: S. V. Nedogoda, et al.
Published: (2020-08-01) -
Dynamics of somatogenic comorbid anxiety-depressive disorders expression under the tiotropium bromide treatment influence
by: S. V. Fedosenko, et al.
Published: (2011-02-01) -
COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD
by: E. G. Kosolapov, et al.
Published: (2017-08-01) -
Efficiency of tiotropium bromide in patients with severe persistent bronchial asthma in clinical practice
by: A. F. Ivanov, et al.
Published: (2018-04-01)